DK1303294T3 - Fremgangsmåde til behandling af instabil angina pectoris - Google Patents

Fremgangsmåde til behandling af instabil angina pectoris

Info

Publication number
DK1303294T3
DK1303294T3 DK01960527T DK01960527T DK1303294T3 DK 1303294 T3 DK1303294 T3 DK 1303294T3 DK 01960527 T DK01960527 T DK 01960527T DK 01960527 T DK01960527 T DK 01960527T DK 1303294 T3 DK1303294 T3 DK 1303294T3
Authority
DK
Denmark
Prior art keywords
angina pectoris
unstable angina
procedure
treatment
hypercholesterolaemia
Prior art date
Application number
DK01960527T
Other languages
Danish (da)
English (en)
Inventor
Thomas F Luescher
Georg Noll
Peter Lerch
Original Assignee
Zl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zl Behring Ag filed Critical Zl Behring Ag
Application granted granted Critical
Publication of DK1303294T3 publication Critical patent/DK1303294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Supports For Pipes And Cables (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01960527T 2000-07-20 2001-07-20 Fremgangsmåde til behandling af instabil angina pectoris DK1303294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10035352A DE10035352A1 (de) 2000-07-20 2000-07-20 Verfahren zur Behandlung von instabiler Angina pectoris

Publications (1)

Publication Number Publication Date
DK1303294T3 true DK1303294T3 (da) 2006-10-30

Family

ID=7649620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01960527T DK1303294T3 (da) 2000-07-20 2001-07-20 Fremgangsmåde til behandling af instabil angina pectoris

Country Status (17)

Country Link
US (1) US7053049B2 (fr)
EP (1) EP1303294B1 (fr)
JP (1) JP4928047B2 (fr)
KR (2) KR20070108955A (fr)
AT (1) ATE333887T1 (fr)
AU (2) AU8200401A (fr)
CA (1) CA2418238C (fr)
DE (2) DE10035352A1 (fr)
DK (1) DK1303294T3 (fr)
ES (1) ES2266234T3 (fr)
HU (1) HU230151B1 (fr)
IL (2) IL154006A0 (fr)
NO (1) NO329848B1 (fr)
NZ (1) NZ523784A (fr)
PL (1) PL204406B1 (fr)
WO (1) WO2002007753A2 (fr)
ZA (1) ZA200300509B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000924A1 (fr) * 2005-06-28 2007-01-04 Osaka University Préparation pharmaceutique comprenant une substance susceptible d'inhiber ou de promouvoir l'activité de la progranuline et méthode de criblage pour la recherche d'une substance susceptible d'inhiber ou de promouvoir l'activité de la progranuline
US7956035B2 (en) * 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
WO2010057203A2 (fr) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Particules de hdl pour administration d'acides nucléiques
EP2900475B1 (fr) 2012-09-25 2018-03-28 Hewlett-Packard Development Company, L.P. Détection de goutte
ITMI20131300A1 (it) * 2013-08-01 2015-02-02 Nobil Bio Ricerche Srl Composizione per il riempimento di difetti ossei e parodontali
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
GB2603950A (en) 2021-02-22 2022-08-24 Reckitt & Colman Overseas Hygiene Home Ltd Effervescent germicidal compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
CA1335077C (fr) * 1988-02-08 1995-04-04 Henri Isliker Mode de fabrication d'apolipoproteines a partir du plasma ou de serum humains
EP0543417A1 (fr) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotriènols et composés sembles à tocotriènol et méthodes pour leur utilisation
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JPH10218861A (ja) * 1997-02-04 1998-08-18 Yamanouchi Pharmaceut Co Ltd 新規なフェネタノール誘導体又はその塩
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
GB9919713D0 (en) * 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
AU777788B2 (en) * 1999-11-26 2004-10-28 Heart Research Institute Limited, The Oxidized apolipoproteins and methods of use
AUPQ429399A0 (en) 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use

Also Published As

Publication number Publication date
DE50110552D1 (de) 2006-09-07
AU8200401A (en) 2002-02-05
HUP0300730A3 (en) 2010-07-28
US7053049B2 (en) 2006-05-30
KR20030026980A (ko) 2003-04-03
WO2002007753A3 (fr) 2003-02-13
DE10035352A1 (de) 2002-01-31
EP1303294B1 (fr) 2006-07-26
ES2266234T3 (es) 2007-03-01
US20040014654A1 (en) 2004-01-22
ZA200300509B (en) 2004-02-17
EP1303294A2 (fr) 2003-04-23
IL154006A (en) 2010-05-31
NO20030137D0 (no) 2003-01-10
PL204406B1 (pl) 2010-01-29
NO20030137L (no) 2003-01-10
HU230151B1 (hu) 2015-09-28
AU2001282004B2 (en) 2006-02-02
KR100864079B1 (ko) 2008-10-16
NZ523784A (en) 2004-06-25
PL366395A1 (en) 2005-01-24
JP2004504355A (ja) 2004-02-12
CA2418238C (fr) 2012-06-05
ATE333887T1 (de) 2006-08-15
HUP0300730A2 (hu) 2003-12-29
KR20070108955A (ko) 2007-11-13
WO2002007753A2 (fr) 2002-01-31
NO329848B1 (no) 2011-01-10
IL154006A0 (en) 2003-07-31
JP4928047B2 (ja) 2012-05-09
CA2418238A1 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
NO20034056D0 (no) Proliferative sykdommer
UY35542A (es) Métodos y composiciones para tratar el virus de la hepatitis c
EA200300953A1 (ru) Терапевтические комбинации для применения при сердечно-сосудистых и воспалительных заболеваниях
CY1110894T1 (el) Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
ME00145B (me) Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
DE60234760D1 (de) Phenylindole zur behandlung von hiv
BR0107691A (pt) Sapogeninas substituìdas e seu uso
DK1112083T3 (da) Behandling af mikrovaskulære angiopatier
DK1429756T3 (da) Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DK1303294T3 (da) Fremgangsmåde til behandling af instabil angina pectoris
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60103685D1 (de) Behandlung von Poriomania
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
WO2002083700A3 (fr) Disaccharides hypersulfates et leur utilisation en traitement contre les inflammations
DE60134885D1 (de) Antiangiogene polypeptide
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion